Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $671.74 | 14 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $345.51 | 3 | $0 (2022) |
| ViiV Healthcare Company | $113.40 | 1 | $0 (2024) |
| Gilead Sciences, Inc. | $75.18 | 3 | $0 (2024) |
| ABBVIE INC. | $37.69 | 2 | $0 (2024) |
| Merck Sharp & Dohme LLC | $25.68 | 1 | $0 (2024) |
| Daiichi Sankyo Inc. | $24.99 | 1 | $0 (2020) |
| Melinta Therapeutics, LLC | $19.06 | 1 | $0 (2024) |
| Insmed, Inc. | $15.96 | 1 | $0 (2024) |
| Novo Nordisk Inc | $14.27 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $286.97 | 9 | ViiV Healthcare Company ($113.40) |
| 2022 | $98.19 | 1 | AstraZeneca Pharmaceuticals LP ($98.19) |
| 2020 | $39.26 | 2 | Daiichi Sankyo Inc. ($24.99) |
| 2019 | $247.32 | 2 | AstraZeneca Pharmaceuticals LP ($247.32) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/11/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $32.91 | General |
| 10/22/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug), Kimyrsa, Orbactiv | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: ANTIFUNGALS | ||||||
| 10/02/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.50 | General |
| 10/01/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/24/2024 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/03/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.77 | General |
| 07/15/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $113.40 | General |
| Category: HIV | ||||||
| 03/22/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $98.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/29/2020 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Anemia | ||||||
| 02/27/2020 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.27 | General |
| 11/12/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 07/31/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $122.32 | General |
About Dr. Danielle Zambrano, DO
Dr. Danielle Zambrano, DO is a Infectious Disease healthcare provider based in Camden, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/18/2019. The National Provider Identifier (NPI) number assigned to this provider is 1538628763.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Danielle Zambrano, DO has received a total of $671.74 in payments from pharmaceutical and medical device companies, with $286.97 received in 2024. These payments were reported across 14 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($671.74).
Practice Information
- Specialty Infectious Disease
- Other Specialties Infectious Disease
- Location Camden, NJ
- Active Since 03/18/2019
- Last Updated 10/03/2025
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1538628763
Products in Payments
- FASENRA (Drug) $125.00
- DOVATO (Drug) $113.40
- FARXIGA (Drug) $98.19
- PIFELTRO (Drug) $25.68
- INJECTAFER (Drug) $24.99
- AVYCAZ (Drug) $21.43
- Rezzayo (Drug) $19.06
- TEFLARO (Drug) $16.26
- Arikayce (Drug) $15.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Camden
Dr. Akinwale Olatosi, M.b.b.s, M.B.B.S
Infectious Disease — Payments: $41,876
Dr. Pola Dela Torre, Md, MD
Infectious Disease — Payments: $16,627
Dana Byrne, Md, MD
Infectious Disease — Payments: $1,885
Henry Fraimow, Md, MD
Infectious Disease — Payments: $1,513
Lisa Pedroza, Md, MD
Infectious Disease — Payments: $650.52
Kevin Ng, M.d, M.D
Infectious Disease — Payments: $330.25